These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1535 related articles for article (PubMed ID: 23360966)

  • 1. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.
    Cho SW; Kim S; Kim JM; Kim JS
    Nat Biotechnol; 2013 Mar; 31(3):230-2. PubMed ID: 23360966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CRISPR/Cas system for genome editing in pluripotent stem cells].
    Vasil'eva EA; Melino D; Barlev NA
    Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro enzymology of Cas9.
    Anders C; Jinek M
    Methods Enzymol; 2014; 546():1-20. PubMed ID: 25398333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases.
    Cho SW; Kim S; Kim Y; Kweon J; Kim HS; Bae S; Kim JS
    Genome Res; 2014 Jan; 24(1):132-41. PubMed ID: 24253446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-guided editing of bacterial genomes using CRISPR-Cas systems.
    Jiang W; Bikard D; Cox D; Zhang F; Marraffini LA
    Nat Biotechnol; 2013 Mar; 31(3):233-9. PubMed ID: 23360965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity.
    Pattanayak V; Lin S; Guilinger JP; Ma E; Doudna JA; Liu DR
    Nat Biotechnol; 2013 Sep; 31(9):839-43. PubMed ID: 23934178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
    Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
    Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationally engineered Cas9 nucleases with improved specificity.
    Slaymaker IM; Gao L; Zetsche B; Scott DA; Yan WX; Zhang F
    Science; 2016 Jan; 351(6268):84-8. PubMed ID: 26628643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex genome engineering using CRISPR/Cas systems.
    Cong L; Ran FA; Cox D; Lin S; Barretto R; Habib N; Hsu PD; Wu X; Jiang W; Marraffini LA; Zhang F
    Science; 2013 Feb; 339(6121):819-23. PubMed ID: 23287718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cas9-based genome editing in Arabidopsis and tobacco.
    Li JF; Zhang D; Sheen J
    Methods Enzymol; 2014; 546():459-72. PubMed ID: 25398353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion guide RNAs for orthogonal gene manipulation with Cas9 and Cpf1.
    Kweon J; Jang AH; Kim DE; Yang JW; Yoon M; Rim Shin H; Kim JS; Kim Y
    Nat Commun; 2017 Nov; 8(1):1723. PubMed ID: 29167440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the specificities of TALENs, Cas9, and other genome-editing enzymes.
    Pattanayak V; Guilinger JP; Liu DR
    Methods Enzymol; 2014; 546():47-78. PubMed ID: 25398335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient genome editing in zebrafish using a CRISPR-Cas system.
    Hwang WY; Fu Y; Reyon D; Maeder ML; Tsai SQ; Sander JD; Peterson RT; Yeh JR; Joung JK
    Nat Biotechnol; 2013 Mar; 31(3):227-9. PubMed ID: 23360964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a CRISPR-Cas9 System for Pig Genome Targeting.
    Su YH; Lin TY; Huang CL; Tu CF; Chuang CK
    Anim Biotechnol; 2015; 26(4):279-88. PubMed ID: 26158460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
    Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
    Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying on- and off-target genome editing.
    Hendel A; Fine EJ; Bao G; Porteus MH
    Trends Biotechnol; 2015 Feb; 33(2):132-40. PubMed ID: 25595557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
    Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease.
    Nekrasov V; Staskawicz B; Weigel D; Jones JD; Kamoun S
    Nat Biotechnol; 2013 Aug; 31(8):691-3. PubMed ID: 23929340
    [No Abstract]   [Full Text] [Related]  

  • 19. Genome editing using Cas9 nickases.
    Trevino AE; Zhang F
    Methods Enzymol; 2014; 546():161-74. PubMed ID: 25398340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient heritable plant genome engineering using Cas9 orthologues from Streptococcus thermophilus and Staphylococcus aureus.
    Steinert J; Schiml S; Fauser F; Puchta H
    Plant J; 2015 Dec; 84(6):1295-305. PubMed ID: 26576927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.